Company intelligence / Profile preview

Wecare Probiotics

Suzhou/Wujiang District, Jiangsu, Chinawecare-life.com ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

Wecare is a leading Chinese manufacturer and developer of probiotic strains and starter cultures with global reach. The company supplies high-potency probiotic powders and derivatives for use in dietary supplements, food products, dairy, precision medicine, personal care, feed additives and pet food. Their products are exported to over 80 countries. They have extensive R&D capabilities with more than 230 researchers and hold numerous international certifications including NSF cGMP, FSSC 22000, ISO 22000. Their founder Dr. Frank Fang is a recognized expert in the field.

Therapeutic areas: OncologyImmunologyOtherDermatologyGastroenterology
Modalities: Live biotherapeutic product therapyMicrobial therapy
Industry: Non-Drug Biotech

Partnerships

Bayer (trusted supplier)

Beyond the preview

Go deeper on Wecare Probiotics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wecare Probiotics.

Explore the full profile